Literature DB >> 9706025

ATP is a potent stimulator of the activation and formation of rodent osteoclasts.

M S Morrison1, L Turin, B F King, G Burnstock, T R Arnett.   

Abstract

1. There is increasing evidence that extracellular ATP acts directly on bone cells via P2 receptors. In normal rat osteoclasts, ATP activates both non-selective cation channels and Ca2+-dependent K+ channels. In this study we investigated the action of ATP on the formation of osteoclasts and on the ultimate function of these cells, namely resorption pit formation. 2. We found that ATP stimulated resorption pit formation up to 5.6-fold when osteoclast-containing bone cell populations from neonatal rats were cultured for 26 h on ivory discs, with a maximum effect occurring at relatively low concentrations (0.2-2 microM). The stimulatory effect of ATP was amplified greatly when osteoclasts were activated by culture in acidified media (pH 6.9-7.0). Pit formation by acid-activated osteoclasts in the absence of ATP was inhibited by apyrase, an ecto-ATPase and by suramin, an antagonist of P2 receptors. 3. Over the same concentration range at which rat osteoclast activation occurred (0.2-2 microM), ATP also enhanced osteoclast formation in 10 day mouse marrow cultures, by up to 3.3-fold, with corresponding increases in resorption pit formation. Higher concentrations of ATP (20-200 microM) reduced or blocked osteoclast formation. Adenosine, a P1 receptor agonist, was without effect on either osteoclast activation or formation. 4. These results suggest that low levels of extracellular ATP may play a fundamental role in modulating both the resorptive function and formation of mammalian osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706025      PMCID: PMC2231120          DOI: 10.1111/j.1469-7793.1998.495bh.x

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  19 in total

1.  Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

2.  A comparative study of disaggregated chick and rat osteoclasts in vitro: effects of calcitonin and prostaglandins.

Authors:  T R Arnett; D W Dempster
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

3.  Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts.

Authors:  W B Bowler; M A Birch; J A Gallagher; G Bilbe
Journal:  J Bone Miner Res       Date:  1995-07       Impact factor: 6.741

Review 4.  The past, present and future of purine nucleotides as signalling molecules.

Authors:  G Burnstock
Journal:  Neuropharmacology       Date:  1997-09       Impact factor: 5.250

5.  Purinergic transmitters inhibit bone formation by cultured osteoblasts.

Authors:  S J Jones; C Gray; A Boyde; G Burnstock
Journal:  Bone       Date:  1997-11       Impact factor: 4.398

6.  Extracellular adenosine triphosphate. A shock to hemopoietic cells.

Authors:  P J Nijweide; W E Modderman; C E Hagenaars
Journal:  Clin Orthop Relat Res       Date:  1995-04       Impact factor: 4.176

7.  ATP induces an intracellular calcium pulse in osteoclasts.

Authors:  H Yu; J Ferrier
Journal:  Biochem Biophys Res Commun       Date:  1993-03-15       Impact factor: 3.575

8.  Mechanisms of ATP-induced Ca2+ signaling in osteoclasts.

Authors:  H Yu; J Ferrier
Journal:  Cell Signal       Date:  1994-11       Impact factor: 4.315

9.  Stimulation of cartilage resorption by extracellular ATP acting at P2-purinoceptors.

Authors:  W S Leong; R G Russell; A M Caswell
Journal:  Biochim Biophys Acta       Date:  1994-11-11

10.  Effect of pH on bone resorption by rat osteoclasts in vitro.

Authors:  T R Arnett; D W Dempster
Journal:  Endocrinology       Date:  1986-07       Impact factor: 4.736

View more
  22 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

3.  Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.

Authors:  Ning Wang; Bernard Robaye; Ankita Agrawal; Timothy M Skerry; Jean-Marie Boeynaems; Alison Gartland
Journal:  Mol Endocrinol       Date:  2011-11-22

4.  Cytosolic proteome profiling of monocytes for male osteoporosis.

Authors:  W Zhu; H Shen; J-G Zhang; L Zhang; Y Zeng; H-L Huang; Y-C Zhao; H He; Y Zhou; K-H Wu; Q Tian; L-J Zhao; F-Y Deng; H-W Deng
Journal:  Osteoporos Int       Date:  2016-11-14       Impact factor: 4.507

5.  Influence of pH on osteoclasts treated with zoledronate and alendronate.

Authors:  Francisco Javier Manzano-Moreno; Javier Ramos-Torrecillas; Elvira de Luna-Bertos; Rebeca Illescas-Montes; Timothy R Arnett; Concepción Ruiz; Olga García-Martínez
Journal:  Clin Oral Investig       Date:  2018-06-06       Impact factor: 3.573

6.  Lack of effect of adenosine on the function of rodent osteoblasts and osteoclasts in vitro.

Authors:  Mark O R Hajjawi; Jessal J Patel; Michelangelo Corcelli; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2016-02-10       Impact factor: 3.765

7.  1alpha,25(OH)(2) vitamin D(3) induction of ATP secretion in osteoblasts.

Authors:  Payal Biswas; Laura P Zanello
Journal:  J Bone Miner Res       Date:  2009-08       Impact factor: 6.741

Review 8.  Calcium signalling and calcium transport in bone disease.

Authors:  H C Blair; P H Schlesinger; C L H Huang; M Zaidi
Journal:  Subcell Biochem       Date:  2007

Review 9.  Energy metabolism: A newly emerging target of BMP signaling in bone homeostasis.

Authors:  Jingwen Yang; Hiroki Ueharu; Yuji Mishina
Journal:  Bone       Date:  2020-06-05       Impact factor: 4.398

10.  Rolofylline, an adenosine A1 receptor antagonist, inhibits osteoclast differentiation as an inverse agonist.

Authors:  Wenjie He; Tuere Wilder; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.